Literature DB >> 9101613

Neurohumoral systems in patients with cirrhosis.

J C Monte, D Casarini, E Parise, N Schor, O F dos Santos.   

Abstract

In order to evaluate the activation of the sympathetic nervous and renin-angiotensin systems and antidiuretic hormone release in the setting of chronic liver disease, we studied 30 patients with cirrhosis who presented normal renal function. The cirrhotic patients were divided into two groups according to Child's score: 20 were Child A and 10 Child B. The control group consisted of 10 normal subjects. Blood samples were collected for determination of norepinephrine (NE), dopamine (DA), angiotensin I and II (AI and AII), and antidiuretic hormone (ADH), using the method of high-performance liquid chromatography (HPLC). No significant differences (p < 0.05) were found in the plasma levels of NE, DA, AI, and AII between the cirrhotic patients and the controls, although the absolute values observed in both groups of cirrhotics were clearly higher than in controls. The ADH levels were higher in Child B in comparison to Child A patients and controls, though this difference was not significant as well. Our results suggest a hormonal activation in cirrhotic patients, even in the early stages of hepatic disease (without ascites). We also noted an increase in ADH levels in Child B patients in relation to Child A and controls, although there was no difference in osmolality, suggesting a non-osmotic ADH release.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101613     DOI: 10.3109/08860229709026298

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  1 in total

1.  Lack of β2 -adrenoceptors aggravates heart failure-induced skeletal muscle myopathy in mice.

Authors:  Vanessa A Voltarelli; Luiz R G Bechara; Aline V N Bacurau; Katt C Mattos; Paulo M M Dourado; Carlos R Bueno; Dulce E Casarini; Carlos E Negrao; Patricia C Brum
Journal:  J Cell Mol Med       Date:  2014-03-13       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.